Attilio Guarini

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 656 citations · Full text

Hematological Malignancy, Neuro-oncology, Lymphoid Neoplasia +9

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 551 citations · Full text

Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis

Erika M. Palmieri, Alessio Menga, Rosa Martín‐Pérez et al. · Cell Reports · 2017 · 360 citations · Full text

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

Ilaria Del Giudice, Davide Rossi, Sabina Chiaretti et al. · Haematologica · 2011 · 185 citations · Full text

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

Sabino Ciavarella, M.C. Vegliante, Marco Fabbri et al. · Annals of Oncology · 2018 · 122 citations · Full text